FastFinder
Artificial intelligence for automated, standardised interpretation of DNA testing results
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0FastFinder project word cloud
Explore the words cloud of the FastFinder project. It provides you a very rough idea of what is the project "FastFinder" about.
Project "FastFinder" data sheet
The following table provides information about the project.
| Coordinator |
UGENTEC NV
Organization address contact info |
| Coordinator Country | Belgium [BE] |
| Project website | http://www.ugentec.com |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-06-01 to 2017-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | UGENTEC NV | BE (HASSELT) | coordinator | 50˙000.00 |
Map
Project objective
UgenTec is an award winning Belgian bio-IT start-up that develops software for automated and standardised analysis of DNA detection tests. Founded in 2014, it is venture backed and as raised a capital of €3.45 million. The company is led by Wouter Uten and Tom Martens, both with a track record in successful business development. UgenTec has a contracted revenue of €427.000, a team of 24 software engineers, data scientists and molecular biologists and is supported by Deloitte, IMEC, KU Leuven university, EIC-ICT labs and Microsoft Innovation Centre Flanders. Public health expenditure in the EU continues to rise with projected growth at 8.5% of GDP in 2060, driven by an ageing population and associated rise in chronic diseases and the promotion of personalised healthcare, demanding molecular information. This highlights an increasing need for automation in molecular diagnostics, including software solutions for interpretation of results. The market for genetic analysis software will grow substantially at 6.9% CAGR already by 2018. There is a clear market pull for automated solutions: as genetic testing volumes are growing every year and quality standards become stricter, the lab budgets are coming under pressure. As a disruptive innovative solution to this problem, UgenTec has developed the FastFinder software platform, advancing state of the art artificial intelligence and machine learning algorithms to automate the interpretation of results in the genetic testing workflow. FastFinder USP allows interpretation 30 times faster than manual interpretation and removes human errors that can lead to serious – and often costly – implications in treatment decisions for patients. Platform application potential extends beyond a clinical setting, (e.g. pharma, food safety) boosting commercial gain. This innovation has a revenue potential for UgenTec of over €100 million within 10 years coupled to the hiring of 100 additional highly skilled employees.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FASTFINDER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "FASTFINDER" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)
Assist (2015)
Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone
Read More